Abiopharma

🔍 Ludwig Jeffrey G. (Executive)

Company: Midland States Bancorp, Inc. (MSBI)

Report Date: 2026-07-28

Detailed Transactions and Holdings:

• Acquired 8,383 shares of Common Stock at $28.59 per share (Direct)
  Date: 2026-07-28 | Code: M | equity_swap_involved: false | shares_owned_after: 409,354.43 | transaction_form_type: 4
• Sold 8,383 shares of Common Stock at $34.0001 per share (Direct)
  Date: 2026-07-28 | Code: S | equity_swap_involved: false | shares_owned_after: 400,971.43 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-28 | Code: H | nature_of_ownership: JQ Properties | shares_owned_after: 11,569.00 | Footnotes: F1
• Sold 8,383 shares of Option (right to buy) at $28.59 per share (Derivative)
  Date: 2026-07-28 | Code: M | Expires: 2026-11-16 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F2
• Holds 52,291 shares of Option (right to buy) at $28.43 per share (Derivative)
  Date: 2026-07-28 | Code: H | Expires: 2032-10-31 | shares_owned_after: 52,291.00 | Footnotes: F3

Footnotes:

• F1: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose
• F2: These options vest in four equal annual installments beginning one year after the 11/16/2016 date of grant.
• F3: These options vest in four equal annual installments beginning one year after the 10/31/2022 date of grant.